NWRD09 for HPV-16 Related Cervical HSIL

NCT07047989 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

High-grade Squamous Intraepithelial Lesion (HSIL)

Interventions

BIOLOGICAL: NWRD09 injection

Sponsor

Newish Biotech (Wuxi) Co., Ltd.